ASH 2013: short review on myeloproliferative neoplasms

Abstract At the 2013 annual meeting of the American Society of Hematology, the role of calreticulin in essential thrombocythemia and primary myelofibrosis as well as safety aspects in second-generation tyrosin kinase inhibitor treatment of chronic myeloid leukemia have been major issues in the field of myeloproliferative neoplasms.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research